Intranasal Oxytocin for Frontotemporal Dementia (FOXY)
Interventional StudyGet in touch about this study
What is the study about?
This study is investigating the effects of oxytocin, a natural hormone in the body, on behavioural symptoms in people with frontotemporal dementia (FTD), compared to placebo.
Eligibility- Who can participate?
- Be 30 to 80 years of age
- Have a diagnosis of frontotemporal dementia (FTD) or known FTD-causing genetic mutations
- Have current symptoms of social apathy/indifference
- Have a study partner
5 visits over 6 months.
TDRA Study Investigators
Sunnybrook: Dr. Mario Masellis
Toronto Western Hospital: Dr. Carmela Tartaglia
Sunnybrook Health Sciences Centre
Address: 2075 Bayview Ave, Toronto, ON M4N 3M5University Health Network (UHN)-Toronto Western Hospital
Address: 399 Bathurst Street, Toronto ON M5T 2S8
30 - 39, 40 - 49, 50 - 54, 55 - 59, 60 - 64, 65 - 69, 70 - 80